Banner for leaf pages 2

Vilazodone (Viibryd)

Also known as Viibryd

Vilazodone (United States trade name Viibryd) is a serotonergic antidepressant developed by Clinical Data for the treatment of major depressive disorder. The chemical compound was originally developed by Merck KGaA (Germany). By 2009 two phase III clinical trials with positive results had been completed. Vilazodone was approved by the FDA for use in the United States to treat major depressive disorder on January 21, 2011.

Source: Wikipedia

What is it prescribed for?

Patients are most commonly prescribed vilazodone to treat rabies, blastomycosis, west nile virus, and pick disease.

What drug interactions are known?

Do not take vilazodone if you are taking any of the following:

Critical Interactions

Significant Interactions

Ajax-loader Loading...